Pancreatic Cancer Research

ResearcherTang Du HospitalActive in the last 2 years

Ronglin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1269-5618; OpenAlex author ID A5103157559. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: 3 papers · 2024: none · 2025: 1 paper

Papers 7

  1. The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice. Co-author DOI 10.1186/s12967-025-06778-8↗
  2. AKR7A3 modulates the metastasis of pancreatic ductal adenocarcinoma through regulating PHGDH-suppressed autophagy. Co-author DOI 10.1111/cas.15798↗
  3. Machine learning-based integration develops a metabolism-derived consensus model for improving immunotherapy in pancreatic cancer. First author DOI 10.1136/jitc-2023-007466↗
  4. Correction: TMEM43 promotes pancreatic cancer progression by stabilizing PRPF3 and regulating RAP2B/ERK axis. Co-author DOI 10.1186/s11658-023-00419-y↗
  5. TMEM43 promotes pancreatic cancer progression by stabilizing PRPF3 and regulating RAP2B/ERK axis. Co-author DOI 10.1186/s11658-022-00321-z↗
  6. Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy. Co-author DOI 10.3389/fonc.2022.851766↗
  7. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer. First author DOI 10.3389/fimmu.2021.769425↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haichuan Su · 7 shared papers, 2021–2025 · strength 1.13
  2. Yongdong Guo · 6 shared papers, 2021–2023 · strength 0.84
  3. Junqiang Li · 5 shared papers, 2021–2025 · strength 0.80
  4. Lei Hua · 5 shared papers, 2021–2023 · strength 0.69
  5. Yang Song · 3 shared papers, 2021–2023 · strength 0.39
  6. Cheng Yang · 3 shared papers, 2021–2022 · strength 0.37
  7. Cheng Yang · 1 shared paper, 2025 · strength 0.28
  8. Qian Li · 1 shared paper, 2025 · strength 0.28
  9. Ting Zhao · 2 shared papers, 2021–2022 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.